These restrictions with the BTNX NTS are hugely pertinent, as we observed e.g. etodesnitazene to acquire the same in vitro potency and efficacy as fentanyl [7, 13] and as it might potentially give PWUD a false perception of protection. On top of that, the detectability of nitazene analogues in drug samples may very well be impacted by solubility di